SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corvas International(CVAS)
CVAS 0.0004000.0%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: x70sxn who wrote (12)12/17/1996 1:56:00 AM
From: Larry Liebman   of 22
 
Here are the numbers...Corvas has 13.7 million shares out..at $4.62/share...that gives a capitalization around $63 million..After today's deal it has around $30 million in cash...Its' technology is being valued at $33 million!! Consider that the Schering deals alone are valued at about $80 million (of course, if they are successful)...then add the collaborations with Pfizer and Centocor...and the kicker, they intend to advance their NAP program on their own to insure a significant cut, and trials are anticipated to begin in early "97...I suggest investor's check out their web-site at www.corvas.com...read the corporate news...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext